Disease | cystic fibrosis |
Symptom | |infections |
Sentences | 163 |
PubMedID- 24300299 | Mp-376 was developed for the management of cystic fibrosis (cf) patients with chronic respiratory infections due to pseudomonas aeruginosa . |
PubMedID- 26019629 | It may cause infections, particularly, in patients with cystic fibrosis, bronchiectasis, neutropenia, acquired immune deficiency syndrome (aids), burns and in those with metabolic, haematologic or malignant diseases. |
PubMedID- 21511763 | P. aeruginosa infections associated with cystic fibrosis are resistant to current therapies, and molecules inhibiting toxin production or signals controlling their production should be able to reduce infection and aid in the clearance of this pathogen. |
PubMedID- 21775220 | Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis. |
PubMedID- 23796134 | Prominent examples of taas are found in burkholderia cepacia complex, a group of bacterial species causing severe infections in patients with cystic fibrosis. |
PubMedID- 25470304 | Objectives: the objective of our review was to compare antibiotic treatment to no antibiotic treatment, or to compare different combinations of antibiotic treatment, for nontuberculous mycobacteria lung infections in people with cystic fibrosis. |
PubMedID- 22208544 | Commercial availability of more than one inhaled antibiotic for the management of chronic pseudomonas aeruginosa lung infections in persons with cystic fibrosis creates a welcome question: can different inhaled therapies be combined to improve patient outcomes. |
PubMedID- 22968160 | Fluoroquinolones are commonly used to treat lung infections in patients with cystic fibrosis. |
PubMedID- 23486248 | Cenocepacia is known for its ability to cause lung infections in people with cystic fibrosis and it possesses a large 8 mb multireplicon genome encoding a wide array of pathogenicity and fitness genes. |
PubMedID- 24452385 | The effect of the weather on pulmonary exacerbations and viral infections among adults with cystic fibrosis. |
PubMedID- 22321740 | Background: burkholderia cenocepacia is an opportunistic pathogen causing life-threatening infections in patients with cystic fibrosis. |
PubMedID- 21811795 | Another similarity is the alginate production in a. vinelandii, which is also a by-product in pathogenic p. aeruginosa infections in the lungs of cystic fibrosis patients . |
PubMedID- 22309106 | The opportunistic pathogen pseudomonas aeruginosa causes life-threatening, persistent infections in patients with cystic fibrosis (cf). |